What is the appropriate nebulized colistimethate sodium (colistin) dose and administration protocol for an adult with a multidrug‑resistant gram‑negative respiratory infection, including renal dose adjustment and pre‑treatment bronchodilator?

Nebulized Colistin Dosing and Administration Protocol

For adults with multidrug-resistant gram-negative respiratory infections, administer nebulized colistimethate sodium at 2 million IU (approximately 160 mg) every 8 hours using a vibrating mesh or ultrasonic nebulizer, always in combination with appropriate intravenous antibiotics, with pre-treatment bronchodilator administration recommended. 1

Dosing Regimen

Standard nebulized dose: 2 million IU every 8-12 hours 1

• Higher doses (5 million IU every 8 hours) have been used in severe cases with colistin-only susceptible organisms and demonstrated safety with superior lung concentrations 2
• The 80 mg (approximately 1 million IU) every 8 hours dose commonly used may be inadequate for multidrug-resistant pathogens 3
• Nebulized therapy should continue for at least 7-14 days, with duration being an independent predictor of microbiological eradication 2

Renal Dose Adjustment

Critical point: Nebulized colistin dosing does NOT require renal adjustment 1, 4

• Systemic absorption from nebulization is minimal, with serum concentrations remaining well below nephrotoxic thresholds 3
• However, if concurrent IV colistin is used, apply standard renal dosing adjustments per the formula: maintenance dose = 2.5 mg × (1.5 × CrCl + 30) twice daily 5

Administration Protocol

Pre-treatment Requirements:

1. Bronchodilator first - Administer short-acting bronchodilator (e.g., albuterol) before colistin nebulization 6
2. Sequence for multiple therapies:
   • Bronchodilators first
   • Mucoactive agents second
   • Airway clearance third
   • Nebulized antibiotics last 6

Nebulizer Selection:

Use vibrating mesh or ultrasonic nebulizers exclusively 1, 7

• Vibrating mesh nebulizers deliver 2.7× more drug than jet nebulizers (53.8 mg vs 19.8 mg inhaled mass) 7
• Particle size of 2.0-2.3 μm is optimal for lower respiratory tract deposition 7
• Jet nebulizers are inferior and should be avoided if possible 1

Preparation:

• Reconstitute 150 mg vial with 2 mL sterile water to achieve 75 mg/mL concentration 4
• For 2 million IU dose: use approximately 2.1 mL of reconstituted solution
• For 5 million IU dose: use approximately 5.3 mL of reconstituted solution
• Dilute to 6 mL total volume with sterile water or normal saline for nebulization 3, 7

Combination Therapy Requirement

Nebulized colistin must ALWAYS be combined with systemic IV antibiotics 1

• Monotherapy with nebulized colistin alone is inadequate
• IV colistin loading dose: 9 million IU, then 4.5 million IU every 12 hours (if CrCl >50 mL/min) 5, 1
• Consider combination with carbapenem or other agents even if non-susceptible (choose lowest MIC) 5

Clinical Indications for Nebulized Therapy

Use nebulized colistin specifically for:

• Non-responsive VAP despite systemic antibiotics 1
• Recurrent VAP 1
• Colistin-only susceptible organisms (e.g., pandrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa) 2
• Isolates with MICs near susceptibility breakpoints 1
• Ventilator-associated tracheobronchitis (may not require concurrent IV therapy in this indication) 1

Monitoring and Safety

Expected Outcomes:

• Epithelial lining fluid concentrations reach 6.7 μg/mL at 1 hour, declining to 2.0 μg/mL at 8 hours 3
• These concentrations exceed MICs for most pathogens at 1-4 hours but may be suboptimal at 8 hours, supporting every-8-hour dosing 3
• Microbiological eradication rates: 40-61% 2, 8
• Clinical cure rates: 60% 2

Adverse Effects:

Bronchospasm risk: 5-8% of patients 1, 9

• Pre-treatment bronchodilators mitigate this risk
• Monitor closely during first administration
• Discontinue if severe bronchospasm occurs

Nephrotoxicity: Minimal with nebulized route alone (same as controls at 22-25%) 9, 2

• Risk increases substantially if combined with IV colistin
• Monitor renal function closely if using both routes 5

Common Pitfalls to Avoid

1. Using jet nebulizers - Results in 60% less drug delivery 7
2. Inadequate dosing - 80 mg every 8 hours is often insufficient; consider 2-5 million IU every 8 hours 3, 2
3. Monotherapy - Never use nebulized colistin without systemic antibiotics for pneumonia 1
4. Skipping bronchodilator - Increases bronchospasm risk 1
5. Applying renal dose adjustments to nebulized route - Not necessary for inhaled administration 1
6. Using for colonization - Nebulized antibiotics should NOT be used for airway colonization without infection 1

Evidence Quality Note

The evidence supporting nebulized colistin is moderate quality, primarily from observational studies and small RCTs. While microbiological eradication improves significantly (OR 2.21), clinical outcomes and mortality benefits remain uncertain 8. However, for colistin-only susceptible organisms with limited alternatives, this represents a rational salvage strategy with acceptable safety profile 1, 2.